TRIM37 has also been shown to promote the proliferation, invasion and migration in breast cancer, lung cancer, gastric cancer, glioma, and pancreatic cancer (Jiang et al., 2016; Li et al., 2018; Tang et al., 2018; Hu et al., 2019; Fu et al., 2020). Here, TRIM37 is linked to breast carcinoma.